According to the FDA, there is no longer a shortage of semaglutide, the active ingredient in the wildly popular Ozempic and Wegovy — a very bad omen for the countless telehealth and pharmacy ...

But 25-year-old Madison Burgess has thrown caution to the wind by opting to micro-dose the drug. The Michigan native revealed ...

From lemon coffee to oatzempic, there's always a new weight loss hack people are buzzing about. The latest of these is ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to the FDA.

U.S. attorneys general urge the FDA to combat counterfeit versions of weight loss drugs developed by Eli Lilly (LLY) and Novo ...

The FOX 5 I-Team's Dana Fowle takes a look at the proposals the group wants withdrawn. Atlanta Chief of Police Darin Schierbaum is speaking publicly for the first time about the case of Treasure ...

Can you explain the specifics of his lawsuit ... If you’re a legal nerd like I am, that’s what makes this so interesting. We’re talking about a case that is testing a lot of areas of ...

Weight loss from GLP-1 meds can cause faces to sag, spurring a big uptick in plastic surgeries to correct so-called 'Ozempic face' Nose ... they often result in issues like volume loss and sagging ...